New!
Portfolio
Login
/
Sign Up
Search
Industries
Technology
Energy
Media
Finance
Green Issues
China
All Concepts
Metals
Energy
Meats
Grains
Softs
ETFs
Indices
Currencies
Geographies
Exchanges
Rates
How To Invest
Personal Finance
Options 101
Definitions
close
close
close
close
Send us Feedback
Omrix Biopharmaceuticals (OMRI)
SUMMARY
BULLS
BEARS
TOPICS
DATA CENTRAL
STOCK CHART
SEC FILINGS
BALANCE
INCOME
CASH FLOW
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
Cash Flow Statement (USD)
Annual
|
Quarterly
QUARTER ENDING
30-SEP
2007
31-DEC
2007
31-MAR
2008
30-JUN
2008
30-SEP
2008
Net Income
3.71M
3.31M
2.09M
2.99M
3.60M
Depreciation
354K
157K
264K
291K
289K
Amortization
-29.0K
272K
123K
123K
-246K
Deferred Taxes
0
0
0
0
0
Change In Working Capital
-682K
-5.51M
403K
-1.29M
-2.71M
Other Non Cash Operating Items
498K
351K
626K
721K
1.57M
Cash From Operations
3.85M
-1.42M
3.51M
2.83M
2.50M
Capital Expenditures
-2.14M
-2.31M
-2.69M
-3.23M
-4.11M
Sale of Assets
0
0
0
0
0
Acquisitions
0
0
0
0
0
Investments
-21.9M
-14.3M
-19.7M
-4.35M
-22.9M
Other Investing Activities
22.1M
24.2M
16.7M
14.7M
27.4M
Cash from Investing
178K
9.83M
-3.04M
10.3M
4.50M
Dividends Paid
0
0
0
0
0
Sale / Purchase of Stock
177K
536K
738K
121K
44.0K
Net Borrowings
-194K
-632K
0
0
0
Other Financing Cash Flows
0
-1000
0
0
0
Cash From Financing
-17.0K
-97.0K
738K
121K
44.0K
Foreign Exchange Effect
92.0K
55.0K
97.0K
4000
-183K
Net Change in Cash
4.11M
8.36M
1.30M
13.3M
6.87M
Add Metric
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
Bet you've never seen portfolio analytics like these.
Introducing
SigFig
— from the creators of
Take Tour